ut-logo website  
 
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

You are here: Home Conferences Conferences GU Cancers Symposium 2012
Bladder Cancer Highlights

Bladder Cancer Highlights

GU Cancers Symposium 2012 - A phase 1 clinical trial of intravesical antisense oligonucleotide targeting heat shock protein (OGX-427) for the treatment of superficial bladder cancer - Session Highlights

  • Print
SAN FRANCISCO, CA, USA (UroToday.com) - Canadian researchers investigated the heat shock protein 27 (hsp 27) and its link to treatment resistance and poor outcomes in superficial bladder cancer.

Read more...